No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
No Data
BioGene Therapeutics to Participate in the 43rd JP Morgan Healthcare Conference
PreveCeutical Announces Change of Auditors
PreveCeutical Medical Advances Gene Therapy With BioGene Therapeutics to Target Diabetes and Obesity | CSE:PREV, OTCQB:PRVCF
BioGene Therapeutics Welcomes Ex Pfizer and Moderna Senior Leadership Dr. Barry Ticho
BioGene Therapeutics Announces Appointment of Dr. Brian Gallagher, Jr. to Corporate Advisory Board
BioGene Therapeutics Welcomes Dr. Deepak Sampath, PhD. to Its Board of Directors